Abstract:Abstract Background: Inflammation and neovascularization are two vital pathological phases of AMD. Recent evidence indicates that blocking P2X7 receptor may relieve inflammation. Here, we investigated whether A740003, a P2X7 receptor antagonist, could prevent retinal inflammation and neovascularization induced by ox-LDL and explored the underlying mechanisms. Methods: ARPE-19 cells were pretreated with A740003 for 2 hours before ox-LDL exposure. Western Blot, ELISA and qPCR were used to detect the proteins and mRNA levels of NLRP3, Caspase-1, P2X7R, pIKBa, IKBa, angiogenic factors and inflammatory cytokines. ROS assay was performed to detect the ROS generation. C57BL/6 mice were subretinally injected with ox-LDL to induce retinal inflammation and neovascularization. A740003 was administrated intraperitoneally starting from day 3 before to day 14 after ox-LDL injection. Retinal function was assessed by dark- and light-adapted ERG. Retinal neovascularization was detected by retinal whole flat mount and immunofluorescence. Thickness of INL and ONL was measured to evaluate the retinal edema. Results: ox-LDL induced inflammatory responses and VEGF overproduction in human RPE cells and mouse retinas. However, A740003 decreased the expression of NLRP3, P2X7R, HIF-1a and VEGF in ARPE-19 cells. Inflammatory cytokines including IL-1b and IL-18 were down-regulated in A740003 treated cells. A740003 suppressed ROS generation and inhibited the phosphorylation of IKBa significantly. Whole flat mount of retinas and immunofluorescence showed that A740003 inhibited the angiogenesis induced by ox-LDL in vivo . The elevated mRNA and protein levels of NLRP3, Caspase-1, P2X7R, HIF-1a and VEGF decreased and IL-1b release was repressed in A740003 treated mice. Besides, the phosphorylation of IKBa was suppressed in the retinas of A740003 treated mice. The retinal edema was alleviated by A740003 treatment. The b- and a-wave amplitudes of ERG were remarkably preserved in A740003 treated mice. Conclusions: A740003 significantly reduced ocular inflammatory responses and VEGF production in ARPE-19 cells. In addition, the P2X7R antagonist reduced retinal inflammation, neovascularization, and protected retinal function in mice. The protective effects were associated with regulating of NLRP3 inflammasome and NF-kB pathway, suppression of ROS generation, as well as inhibition of angiogenic factors.

P2X7 Receptor Antagonist Attenuates Retinal Inflammation and Neovascularization Induced by Oxidized Low-Density Lipoprotein

P2X7 Receptor Antagonist Attenuates Retinal Inflammation and Neovascularization Induced by Oxidized Low Density Lipoprotein

Baicalin Alleviates Age-Related Macular Degeneration via miR-223/NLRP3-Regulated Pyroptosis.

Inhibition of APE1/Ref-1 Redox Activity Rescues Human Retinal Pigment Epithelial Cells from Oxidative Stress and Reduces Choroidal Neovascularization

Neuroprotection of the P2X7 receptor antagonist A740003 on retinal ganglion cells in experimental glaucoma

Downregulation of Inflammatory Response via Nrf2/Trx1/TXNIP Axis in Oxidative Stress-Induced ARPE-19 Cells and Mouse Model of AMD

17Β-Estradiol Protects the Retinal Nerve Cells Suppressing TLR2 Mediated Immune-Inflammation and Apoptosis from Oxidative Stress Insult Independent of PI3K

Liver X Receptor Agonist Inhibits Oxidized Low-Density Lipoprotein Induced Choroidal Neovascularization via the NF-κB Signaling Pathway

Inflammatory Cytokine Secretion And Toll-Like Receptor 4 Activation In Retinal Pigment Epithelium Induced By Oxidized Low-Density Lipoprotein

LXA4 protects against blue-light induced retinal degeneration in human A2E-laden RPE cells and Balb-c mice

Ox-Ldl Up-Regulates The Vascular Endothelial Growth Factor-To-Pigment Epithelium-Derived Factor Ratio In Human Retinal Pigment Epithelial Cells

Activation of LXRs Reduces Oxysterol Lipotoxicity in RPE Cells by Promoting Mitochondrial Function

RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation

Rhodium nanozyme mitigates RPE degeneration and preserves vision in age-related macular degeneration via antioxidant and anti-inflammatory mechanisms

Temporary alleviation of MAPK by arbutin alleviates oxidative damage in the retina and ARPE-19 cells

Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.

PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis

The Role Of Pterostilbene In Treating Aged Related Macular Degeneration And Mechanism Study

Apigenin-7-Diglucuronide Protects Retinas Against Bright Light-Induced Photoreceptor Degeneration Through the Inhibition of Retinal Oxidative Stress and Inflammation

Salvianolic Acid A Protects Retinal Pigment Epithelium from Ox-Ldl-Induced Inflammation in an Age-Related Macular Degeneration Model

PFKFB3 knockdown attenuates Amyloid β-Induced microglial activation and retinal pigment epithelium disorders in mice